Evaluación de la implementación de un programa de atención farmacéutica para pacientes del programa de fibrosis quística del Instituto Nacional del Tórax
No hay miniatura disponible
Archivos
Fecha
2023
Autores
Profesor/a Guía
Facultad/escuela
Idioma
es
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Andrés Bello
Nombre de Curso
Licencia CC
Licencia CC
Resumen
Antecedentes: La fibrosis quística es una enfermedad genética autosómica
recesiva, crónica y multisistémica, donde los pacientes utilizan concomitantemente 3
o más medicamentos desde su diagnóstico, lo que puede llevar a problemas
relacionados a medicamentos (PRMs), es por esto, que nace la necesidad de
implementar un programa de atención farmacéutica, cuyo objetivo es evaluar,
identificar y resolver los principales PRM presentes en estos pacientes.
Objetivo: Evaluar la implementación de un programa de atención farmacéutica para
los pacientes del programa de fibrosis quística del Instituto Nacional Del Tórax.
Metodología: Se diseñó un estudio cuasi-experimental longitudinal prospectivo sin
grupo de control con enfoque mixto. Primero, se adaptó la “Encuesta de adherencia y
factores asociados” para fibrosis quística. Mediante esta encuesta adaptada se
evaluó a los pacientes del programa de fibrosis quística del Instituto Nacional del
Tórax utilizando el método de seguimiento fármaco terapéutico (SFT).
Resultados: En el periodo de estudio se encontraron 38 PRMs de los cuales 29
(76,3%) lograron ser intervenidos y resueltos, siendo los de mayor prevalencia la
adherencia y los problemas por efectos indeseados de los medicamentos. Además,
se evaluó de muy buena manera el aporte del químico farmacéutico dentro del
equipo multidisciplinario por los pacientes.
Conclusión: La atención farmacéutica permitió identificar los principales problemas
relacionados a los medicamentos que presentan los pacientes con fibrosis quística,
logrando el manejo y la resolución de estos. Además, se observó una tendencia
positiva hacia la labor del químico farmacéutico de atención ambulatoria. Se sugiere
seguir estudiando más estrategias para el manejo de PRMs.
Background: Cystic fibrosis (CF) is a genetic autosomal recessive, chronic multisystemic disease, where patients concomitantly use 3 or more drugs from diagnosis, which can lead to drug-related problems (DRPs). Thus, there is a need to implement a pharmacy-based therapy management program, to evaluate, identify and resolve the main DRPs present in these patients. Objetive: To evaluate the implementation of a pharmaceutical care program for patients from the cystic fibrosis program of the National Thorax Institute. Method: A prospective quasi-experimental longitudinal study without control group with mixed approach was designed. First, we adapted the “Adhesion and Associated factors survey” to CF. Using the adapted survey, patients from the cystic fibrosis program of the National Thoracic Institute were evaluated, employing the therapeutic drug monitoring (TDM) method. Results: In the study period, 38 DRPs were found, with 29 (76.3%) of them treated and resolved. Adherence and problems due to undesired effects of the drugs were the most prevalent DRPs. In addition, the contribution of pharmacists within the multidisciplinary team, was highly rated by patients. Conclusion: Pharmacy-based therapy management allowed the identification of the main problems related to the drugs showed by patients with cystic fibrosis, achieving the management and resolution of them. Also, a positive trend towards the work of pharmacists in outpatient care were observed. The study suggest to keep studying strategies for managing DRPs.
Background: Cystic fibrosis (CF) is a genetic autosomal recessive, chronic multisystemic disease, where patients concomitantly use 3 or more drugs from diagnosis, which can lead to drug-related problems (DRPs). Thus, there is a need to implement a pharmacy-based therapy management program, to evaluate, identify and resolve the main DRPs present in these patients. Objetive: To evaluate the implementation of a pharmaceutical care program for patients from the cystic fibrosis program of the National Thorax Institute. Method: A prospective quasi-experimental longitudinal study without control group with mixed approach was designed. First, we adapted the “Adhesion and Associated factors survey” to CF. Using the adapted survey, patients from the cystic fibrosis program of the National Thoracic Institute were evaluated, employing the therapeutic drug monitoring (TDM) method. Results: In the study period, 38 DRPs were found, with 29 (76.3%) of them treated and resolved. Adherence and problems due to undesired effects of the drugs were the most prevalent DRPs. In addition, the contribution of pharmacists within the multidisciplinary team, was highly rated by patients. Conclusion: Pharmacy-based therapy management allowed the identification of the main problems related to the drugs showed by patients with cystic fibrosis, achieving the management and resolution of them. Also, a positive trend towards the work of pharmacists in outpatient care were observed. The study suggest to keep studying strategies for managing DRPs.
Notas
Seminario (Química Farmacéutica)
Palabras clave
Atención Farmacéutica, Evaluación, Fibrosis Quística